Aristotle Atlantic Partners, LLC Guardant Health, Inc. Transaction History
Aristotle Atlantic Partners, LLC
- $3.26 Billion
- Q2 2025
A detailed history of Aristotle Atlantic Partners, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 931,956 shares of GH stock, worth $60.9 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
931,956
Previous 964,521
3.38%
Holding current value
$60.9 Million
Previous $41.1 Million
18.03%
% of portfolio
1.49%
Previous 1.4%
Shares
26 transactions
Others Institutions Holding GH
# of Institutions
416Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$795 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$734 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$325 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$314 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$278 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.68B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...